NKTR (Nektar Therapeutics) Pangali Forward P/E

Logo korporat perusahaan Nektar (NKTR)

Nektar Therapeutics (NKTR) revenues rely on counterparty milestone payments for progress in developing immunotherapies and license royalties. The company's forward P/E ratio confirms this trend, with 0.00 serving as the current metric level. Green chemistry principles dictate an environmentally friendly approach to substance disposal, while equipment modernization at production sites ensures there is no capacity depreciation.

Prakiraan rega marang bathi: Nektar Therapeutics Inc. (NKTR) kanggo 04.07.2022 - 17.11.2026

Rincian analitis perusahaan Nektar Therapeutics

- rega saiki lan proyeksi nilai saham:
Ringkesan analitik perusahaan:nektar.com
Sampel barang Nektar Therapeutics

Assessing the fundamental value of Nektar Therapeutics (NKTR) requires an analysis of market expectations regarding future earnings. This ratio compares the current share price to the projected earnings per share. The trend in the issuer's forward P/E reflects a shift in investor sentiment concerning capital efficiency. For Nektar Therapeutics (NKTR), this indicator captures market confidence in the success of new immuno-oncology developments. A decline in this metric would confirm the effectiveness of cost restructuring against the backdrop of existing cash reserves.

Pesaing Nektar Therapeutics (NKTR)

Prakiraan rega marang bathi ARGX (Argenx)|BNTX (BioNTech Group) - Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E ABVX (Abivax SA)|Kapitalisasi marang proyeksi bathi admabiologics.com (ADMA)|PTGX - Rega marang bathi mangsa ngarep|Immunovant Inc (IMVT) - Prakiraan rega marang bathi|Kiniksa Corp (KNSA) - Rega marang bathi mangsa ngarep|Prakiraan rega marang bathi Grifols, S.A.|Prakiraan rega marang bathi ADPT|Pangali Forward P/E celldex.com|Rega marang bathi mangsa ngarep Aurinia Pharma (AUPH)|BioCryst Pharmaceuticals - Rasio rega marang bathi mangsa ngarep|Pangali Forward P/E VERA (veratx.com)|Dianthus Pharma (DNTH) - Rasio prakiraan rega marang bathi|PHVS - Rega marang bathi mangsa ngarep|ABCL - Pangali Forward P/E|Tourmaline (TRML) - Rega marang bathi mangsa ngarep|Precigen - Pangali mangsa ngarep rega marang bathi|PHAR (Pharming Group NV) - Pangali Forward P/E|UPB (Upstream Pharma) - Rasio kapitalisasi marang bathi mangsa ngarep|Pangali Forward P/E ZBIO|Pangali Forward P/E immunome.com (IMNM)|Pangali Forward P/E GOSS (gossamerbio.com)|Kapitalisasi marang proyeksi bathi KalVista Pharma (KALV)|SEPN - Rega marang bathi mangsa ngarep|Kapitalisasi marang proyeksi bathi Pieris Pharmaceuticals PVLA|SVRA (Savara Inc.) - Prakiraan rega marang bathi|Rasio rega marang bathi sing dikarepake RIGL (Rigel Pharmaceuticals)|ANAB (AnaptysBio) - Pangali Forward P/E|ATXS (Astria Therapeutics, Inc.) - Rasio kapitalisasi marang bathi mangsa ngarep|Rega marang bathi mangsa ngarep engene.com (ENGN)|RAPT (RAPT Therapeutics, Inc.) - Pangali mangsa ngarep rega marang bathi|Aerovate Therapeutics - Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi ACRS|Kyverna Therapeutics, Inc - Pangali Forward P/E|Rasio rega marang bathi sing dikarepake TLSA|CABA: Pangali Forward P/E|Prakiraan rega marang bathi Ventyx Bio|Rega marang bathi mangsa ngarep Theratechnologies, Inc.|Rasio prakiraan rega marang bathi Avalo Therapeutics AVTX|Pangali Forward P/E ELDN|AGEN (Agenus, Inc.) - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Climb Bio, Inc. CLYM|Zura Bio Limited (ZURA) - Rasio prakiraan rega marang bathi|ATYR: Prakiraan rega marang bathi|adagene.com (ADAG) - Prakiraan rega marang bathi|Ikena Oncology (IMA) - Rega marang bathi mangsa ngarep|Prakiraan rega marang bathi Shattuck Labs, Inc.|Rega marang bathi mangsa ngarep equilliumbio.com|Prakiraan rega marang bathi connectbiopharm.com (CNTB)|Pangali Forward P/E IMUX|Kapitalisasi marang proyeksi bathi Atara Bio|Rega marang bathi mangsa ngarep InflaRx N.V. IFRX|X4 Pharmaceuticals - Rega marang bathi mangsa ngarep|ACET: Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi CELU (celularity.com)|INMB: Pangali Forward P/E|BRNS: Rasio kapitalisasi marang bathi mangsa ngarep|KZR (Kezar Life Sciences, Inc.) - Pangali Forward P/E|SAB Biotherapeutics Inc. (SABS) - Kapitalisasi marang proyeksi bathi|Pangali Forward P/E AKTX|Rega marang bathi mangsa ngarep ENLV (Enlivex Therapeutics Ltd)|Rega marang bathi mangsa ngarep Q32 Bio Inc. QTTB|GOVX - Prakiraan rega marang bathi|EDSA - Rega marang bathi mangsa ngarep|Rasio prakiraan rega marang bathi iBio|CARM: Pangali Forward P/E|Rasio rega marang bathi sing dikarepake XTLB (XTL Biopharmaceuticals, Ltd.)|Rega marang bathi mangsa ngarep boltbio.com|Pangali Forward P/E HCW Biologics|Pangali Forward P/E APVO|AIM - Rasio prakiraan rega marang bathi|Pangali Forward P/E ADTX (Aditxt Inc.)|Kapitalisasi marang proyeksi bathi GRI Bio, Inc. (GRI)|XRTX - Rega marang bathi mangsa ngarep|reshapelifesciences.com (HIND) - Prakiraan rega marang bathi|REVB: Pangali Forward P/E|Indaptus Therapeutics, Inc. - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Scinai|Rasio prakiraan rega marang bathi CalciMedica, Inc. CALI|Rega marang bathi mangsa ngarep Affimed NV (AFMD)|Pangali Forward P/E Allakos Inc (ALLK)|Rega marang bathi mangsa ngarep hookipapharma.com HOOK|Pangali Forward P/E IGM Biosciences, Inc. IGMS|iTeos Pharma - Pangali Forward P/E|OCEA - Pangali Forward P/E|TCBP: Pangali Forward P/E|Third Harmonic Bio - Pangali mangsa ngarep rega marang bathi